GARODIA CHEMICALS LTD.

Garodia Chemicals Ltd has announced the closure of its trading window for dealing in equity shares. This closure is in compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015. The window will be shut from Wednesday, July 1, 2026, and will reopen 48 hours after the declaration of the company's Unaudited Financial Results for the quarter ended June 30, 2026. The exact date of the board meeting to consider these results will be communicated later. Designated persons and their immediate relatives are prohibited from trading in the company's securities during this period.

Garodia Chemicals Ltd. announced its audited financial results for the quarter and year ended March 31, 2026. The Board of Directors approved the results in a meeting held on May 29, 2026. The statutory auditors issued an unmodified opinion on the financial results. Revenue from operations was ₹405.88 lakhs. The company's paid-up equity share capital has been reorganized as per the Base Resolution Plan (BRP) approved by the NCLT.

Garodia Chemicals Ltd. approved the audited financial results for the quarter and financial year ended March 31, 2026, in a board meeting held on May 29, 2026. The statutory auditors, Laxmikant Kabra & Co LLP, issued an audit report with an unmodified opinion. The company's other income includes settlement of loans of ₹405.88 lakhs. The existing paid-up equity share capital has been reduced and new equity shares have been allotted as per the Base Resolution Plan approved by NCLT.

Garodia Chemicals Ltd's board approved the audited financial results for the quarter and financial year ended March 31, 2026, during a meeting held on May 29, 2026. The statutory auditors, Laxmikant Kabra & Co LLP, issued an audit report with an unmodified opinion on these results. The trading window for designated persons had been closed from April 1, 2026, and will remain closed until 48 hours after the declaration of the results. The board meeting commenced at 04:30 P.M. and concluded at 06:30 P.M.

Garodia Chemicals Ltd has scheduled a Board of Directors meeting on May 29, 2026, to consider and approve the Audited Financial Results for the quarter and financial year ended March 31, 2026. The trading window is closed from April 01, 2026, and will reopen 48 hours after the declaration of the results.

Garodia Chemicals Ltd announced the resignation of Mrs. Bhagyashri Nilesh Devrale from her position as Non-Executive Director, effective April 22, 2026. The company stated that her resignation is due to personal/professional reasons, as confirmed in her resignation letter. The company also confirmed that there are no other material reasons for her departure from the Board of Directors. This change is reported in compliance with SEBI Listing Regulations.

Garodia Chemicals Ltd announced the resignation of Mrs. Bhagyashri Nilesh Devrale, a Non-Executive Director, effective April 22, 2026. The company informed the stock exchanges as per SEBI Listing Regulations. Mrs. Devrale cited "personal/professional reasons" for her departure, and the company confirmed that there are no other material reasons for her resignation from the Board of Directors. The required details and her resignation letter were included in the filing.

Garodia Chemicals Ltd announced the resignation of Mrs. Bhagyashri Nilesh Devrale, a Non-Executive Director, effective April 22, 2026. The company informed the stock exchange in compliance with SEBI Listing Regulations. Mrs. Devrale cited personal/professional reasons for her departure, and the company confirmed that no other material reasons were provided for her resignation from the Board of Directors.

Garodia Chemicals Ltd has issued a clarification regarding the record date for its share capital reduction. The previous record date of March 25, 2026, for the public category's share capital reduction, has been withdrawn. The company now clarifies that as per a BSE notice dated December 05, 2025, the record date for the reconstitution of share capital is December 10, 2025. This reconstitution involves the extinguishment of 37,28,800 equity shares held by promoters, representing 51.79% of the company's shareholding, without any payment. Additionally, public shareholders will receive 1 new equity share for every 13 existing equity shares held. The face value of public shareholders' shares will also be reduced from ₹10 each to Re. 1 each.

Garodia Chemicals Ltd has issued a clarification regarding the record date for its share capital reduction. The company confirmed that the previously intimated record date of March 25, 2026, for the reduction of share capital in the public category, has been withdrawn. The correct record date, as per BSE's notice dated December 05, 2025, is December 10, 2025. The capital reconstitution plan includes three key components: the extinguishment of 3,728,800 equity shares held by promoters, representing 51.79% of the company's shareholding, without any payment; public shareholders will receive one new equity share for every thirteen existing shares; and the face value of public shareholders' shares will be reduced from ₹10 each to ₹1 each. This clarification aims to avoid any ambiguity regarding the record date and the details of the capital reduction.